Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone.

ABSTRACT:

Purpose

The purpose of this study was to report the functional and anatomical outcomes of a prospective study resulting from repeated dexamethasone intravitreal implants in patients with uveitic refractory macular edema.

Methods

Twelve eyes of 9 patients with intermediate and posterior noninfectious inflammatory uveitis complicated with refractory macular edema were regularly reviewed after a dexamethasone intravitreal implant. Patients were examined at baseline, 30, 90, 135, and 180 days with best-corrected visual acuity (BCVA), complete slit-lamp examination, intraocular pressure (IOP), optical coherence tomography, and fluorescein angiography. After 6 months of follow-up, eyes were reassessed to receive a second implant.

Results

BCVA significantly improved when com

SUBMITTER: Zola M 

PROVIDER: S-EPMC5685094 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature